Wrestling with the RAS cancer drug pipeline

IF 122.7 1区医学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Nature Reviews. Drug Discovery Pub Date : 2025-03-14 DOI:10.1038/d41573-025-00043-9

Asher Mullard

引用次数: 0

Abstract

Alice Shaw, Chief of Strategic Partnerships at Dana-Farber Cancer Institute, discusses the newly launched Center for RAS Therapeutics. Alice Shaw, Chief of Strategic Partnerships at Dana-Farber Cancer Institute, discusses the newly launched Center for RAS Therapeutics.

Abstract Image

查看原文本刊更多论文

与RAS癌症药物管道角力

Alice Shaw，丹娜-法伯癌症研究所战略合作伙伴关系主管，讨论新成立的RAS治疗中心。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews. Drug Discovery 医学-生物工程与应用微生物

CiteScore

137.40

自引率

0.30%

发文量

227

期刊介绍： Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. Each issue includes: Highest-quality reviews and perspectives covering a broad scope. News stories investigating the hottest topics in drug discovery. Timely summaries of key primary research papers. Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.